Holen Sie sich die Stockscreener-App
3.33
5.67%
-0.20
Handel nachbörslich:
3.49
0.16
+4.80%
Schlusskurs vom Vortag:
$3.53
Offen:
$3.6
24-Stunden-Volumen:
1.84M
Relative Volume:
2.37
Marktkapitalisierung:
$510.06M
Einnahmen:
$10.00M
Nettoeinkommen (Verlust:
$-29.47M
KGV:
-11.04
EPS:
-0.3015
Netto-Cashflow:
$-21.55M
1W Leistung:
-22.20%
1M Leistung:
-27.92%
6M Leistung:
+4.06%
1J Leistung:
+60.10%
1-Tages-Spanne:
$3.175
$3.60
1-Wochen-Bereich:
$3.175
$4.29
52-Wochen-Spanne:
$1.86
$5.02
Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile
Firmenname
Mereo Biopharma Group Plc Adr
Sektor
Branche
Telefon
4403330237300
Adresse
ONE CAVENDISH PLACE, LONDON
Vergleichen Sie MREO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MREO | 3.33 | 510.06M | 10.00M | -29.47M | -21.55M | -0.3015 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-13 | Fortgesetzt | BTIG Research | Buy |
| 2022-08-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-05-05 | Eingeleitet | BTIG Research | Buy |
| 2021-04-05 | Eingeleitet | Needham | Buy |
Mereo Biopharma Group Plc Adr Aktie (MREO) Neueste Nachrichten
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Do investors need to be concerned about Mereo Biopharma Group Plc ADR (MREO)? - US Post News
Mereo Biopharma Group Plc ADR (MREO) gets rating Initiated from Robert W. Baird - Knox Daily
JP Morgan analysts upgrades an Overweight rating for Nucor Corp. (NUE) - Knox Daily
KeyBanc Capital Markets initates Alignment Healthcare Inc (ALHC) stock to a Sector weight - Knox Daily
Trading Day Review: Mereo Biopharma Group Plc ADR (MREO) Loses Momentum, Closing at 4.16 - The Dwinnex
Natera Inc (NTRA) receives a Buy rating from Jefferies - Knox Daily
Barclays initates Reinsurance Group Of America, Inc. (RGA) stock to an Overweight - Knox Daily
Recent Insider Activity Suggests Potential Gains for Mereo Biopharma Group Plc ADR (MREO) - Knox Daily
Potential Price Increase for Portland General Electric Co (POR) After Recent Insider Activity - Knox Daily
Analysts review KLA Corp.’s rating - Knox Daily
Perhaps timely catching Mereo Biopharma Group Plc ADR (MREO) would be a good idea - SETE News
MREO Stock Sees Surge of Approximately 7.32% in Last Five Days - Knox Daily
Stocks of Mereo Biopharma Group Plc ADR (MREO) are poised to climb above their peers - SETE News
Monitoring Mereo Biopharma Group Plc ADR (MREO) after recent insider movements - Knox Daily
Mereo Biopharma Group Plc ADR (MREO)’s stock price in review: A technical analysis - US Post News
Market Recap Check: Mereo Biopharma Group Plc ADR (MREO)’s Positive Finish at 4.14, Up/Down 0.98 - The Dwinnex
Mereo Biopharma's SWOT analysis: rare disease biotech stock shows promise By Investing.com - Investing.com South Africa
Mereo Biopharma's SWOT analysis: rare disease biotech stock shows promise - Investing.com
Mereo Biopharma Group Plc ADR [NASDAQ: MREO] Sees Increase in Stock Value - Knox Daily
A Look at Mereo Biopharma Group Plc ADR (MREO) Shares in the Recent Past Indicates Growth - SETE News
Examining Mereo Biopharma Group Plc ADR (MREO) more closely is necessary - US Post News
Xylem Inc [XYL] stock was sold by Harker Victoria D at the price of US$0.35 million - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
MULN’s latest rating updates from top analysts. - Knox Daily
Truist analysts initates a Hold rating for Expedia Group Inc (EXPE) - Knox Daily
Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex
Investing in Twist Bioscience Corp (TWST): What You Must Know - Knox Daily
OKX Ventures and Aptos Foundation Announce First Four Projects Selected for the Ankaa Accelerator Program - GlobeNewswire Inc.
Canopy Growth Corporation [CGC] Shares Fall -2.45 % on Wednesday - Knox Daily
Mereo Biopharma Group Plc ADR (MREO) stock: A year of ups and downs - US Post News
Mereo Biopharma Group Plc ADR (MREO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Mereo BioPharma CFO sells over $120k in company stock - Investing.com India
Mereo BioPharma CFO sells over $121k in company stock - Investing.com
Mereo BioPharma CEO sells over $381k in company stock - Investing.com
Mereo BioPharma's chief scientific officer sells shares worth over $69,000 - Investing.com India
Mereo BioPharma's general counsel sells over $133k in company stock - Investing.com India
Mereo BioPharma executive sells over $637k in company stock - Investing.com
Views of Wall Street’s Leading Experts on Mereo Biopharma Group Plc ADR - SETE News
Market Recap: Mereo Biopharma Group Plc ADR (MREO)’s Negative Momentum, Closing at 4.28 - The Dwinnex
The Potential Rise in the Price of Brixmor Property Group Inc (BRX) following insiders activity - Knox Daily
Taking a Closer Look At Replimune Group Inc (REPL) Following Its Recent Trade - Knox Daily
Mereo Biopharma Group Plc ADR (MREO) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Par Pacific Holdings Inc [PARR] stock for 224,940 USD was sold by Guerra Ivan Daniel - Knox Daily
Evolv Technologies Holdings Inc [EVLV] Shares Rise 1.03 % on Wednesday - Knox Daily
PDCO Shares Experience Surge in Value - Knox Daily
A year in review: Mereo Biopharma Group Plc ADR (MREO)’s performance in the last year - US Post News
Mereo Biopharma Group Plc ADR (MREO)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Mereo Biopharma Group Plc ADR (MREO) receives an Outperform rating from Robert W. Baird - Knox Daily
Monster Beverage Corp. [MNST] Insider Activity: An Update for Investors - Knox Daily
Finanzdaten der Mereo Biopharma Group Plc Adr-Aktie (MREO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):